Store
Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 13th Edition
Publication Date: June 3, 2026
Tags: Blood, Blood Screening, Cancer, Cardiovascular Disease, Coagulation, COVID-19, Diagnostics, Drug Testing, Fertility, Glucose, HbA1c, In Vitro Diagnostics (IVD), Infectious Diseases, Microbiology, Oncology and Cancer, POC, Point of Care, Pregnancy
Pages: 313
SKU: 26-036KA
Now in its thirteenth edition — Worldwide Market for Point-of-Care (POC) Diagnostic Tests analyzes the global POC diagnostics market with updated insights and forecasts through 2030.
Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 13th Edition delivers a comprehensive, forward-looking evaluation of one of the most strategically important segments of the in vitro diagnostics (IVD) industry. As healthcare systems continue to shift toward faster, decentralized, and patient-centered care models, point-of-care testing has moved beyond a niche role to become an essential component of clinical decision-making and disease management.
This edition reflects a market that has fundamentally evolved following the COVID-19 pandemic. POC testing is now widely accepted across providers, payers, and patients as a critical extension of laboratory services, enabling rapid results in hospitals, emergency departments, physician offices, pharmacies, and increasingly in the home. The report examines how this structural shift—combined with staffing shortages, pressure to reduce laboratory turnaround times, and demand for near-patient diagnostics—is driving sustained investment and innovation across the sector.
Growth in the POC market is being fueled by several converging forces: the rising global burden of chronic and infectious diseases, aging populations, expanding access to healthcare in emerging markets, and strong patient preference for convenient, rapid testing. At the same time, advances in miniaturization, microfluidics, biosensors, and cartridge-based molecular platforms are significantly expanding the range and complexity of tests that can be performed outside the central laboratory. Molecular point-of-care testing, in particular, is one of the fastest-growing areas, enabling highly sensitive detection of respiratory infections, sexually transmitted infections, healthcare-associated pathogens, and antimicrobial resistance markers in decentralized settings.
The report also highlights the increasing importance of connectivity and digital integration in POC diagnostics. Newer systems are delivering quantitative, lab-quality results with seamless integration into electronic health records, laboratory information systems, and remote care platforms. Artificial intelligence, clinical decision support tools, and cloud-based data management are expected to play a growing role as diagnostic data becomes more integrated into broader care pathways. These capabilities are becoming critical differentiators for manufacturers, as healthcare providers demand solutions that combine analytical performance with workflow efficiency and regulatory compliance.
Another defining trend covered in this edition is the rapid expansion of home testing and pharmacy-based diagnostics. Building on pandemic-era adoption, consumer-directed testing is gaining traction across infectious disease, sexual health, and chronic disease monitoring. This shift is pushing manufacturers to design simpler, connected, and clinically actionable tests that are supported by digital tools, telehealth integration, and clear patient guidance. The convergence of POC testing and remote patient monitoring is also creating new opportunities in areas such as diabetes, cardiovascular disease, and anticoagulation management.
The study provides in-depth segmentation across key diagnostic categories—including glucose and diabetes monitoring, cardiac markers, infectious disease testing, blood gases and electrolytes, coagulation, urinalysis, pregnancy and fertility, cancer markers, and other specialty tests—offering detailed market sizing, growth projections, and competitive analysis. Each segment is evaluated in the context of evolving care delivery models, technological innovation, and reimbursement dynamics.
Enhanced Segmentation
The report delivers detailed analysis across all major POC testing categories, including:
- Blood and Electrolytes
- Cancer Tumor Markers
- Cardiac Markers
- Coagulation
- Colon Cancer
- Drugs of Abuse
- Fecal Occult Blood
- Glucose (including CGM and HbA1c)
- Infectious Disease (including COVID-19, HIV, Hepatitis, STIs, respiratory testing, and OTC/self-testing)
- Lipid
- Pregnancy and Fertility
- Urine
- Other Testing (including microbiology, TSH, allergy, autoimmune, and specialty assays)
Each category includes market sizing, competitive positioning, and five-year forecasts 2025-2030.
Scope and Methodology
The report provides global coverage, with analysis spanning the United States, Europe, Japan, and emerging markets, along with regional demand drivers and healthcare system dynamics. It evaluates the impact of regulatory frameworks—including CLIA waiver pathways and international approval processes—as well as reimbursement trends and evidence requirements shaping adoption.
Market estimates are presented at the manufacturer level, with 2025 as the base year and forecasts through 2030. The analysis incorporates primary and secondary research, including interviews with industry stakeholders, and assesses growth drivers such as decentralization of care, expansion of molecular POC testing, connectivity requirements, and the transition toward value-based healthcare.
Chapter 1: Executive Summary
About Kalorama Information
Introduction
Scope and Methodology
Size and Growth of the Market
- Table 1-1: Global POC Test Market, 2025-2030 (US$ millions, manufacturer level)
- Figure 1-1: Global POC Test Market, 2025-2030 (US$ millions, manufacturer level)
Trends Affecting the Market
Competitive Outlook
Conclusions
Conclusion One: Tariffs Affecting the POC Market
Conclusion Two: Rapid Molecular POC Tests Growing
Conclusion Three: Multiplex Expansion Beyond COVID and Flu
Conclusion Four: Reimbursement Issues Still Loom
Conclusion Five: PAMA Affects POC Adoption
Conclusion Six: China’s Volume-Based Procurement Putting Pressure on POC Companies
Chapter 2: Introduction and Overview
Scope
Point-of-Care Diagnostics Testing
Industry Regulations
Types of CLIA Certificates
POC Industry Drivers
Patient-focused drivers
Medical/Healthcare-related drivers
Technology drivers
Economic drivers
Other drivers
POC Industry Challenges
POC Test Types
Blood
Urine
Saliva
Hair
Optical Technologies
Breath
Conditions Evaluated by POC Diagnostic Testing
Cancer
Colorectal Cancer
Prostate Cancer
Cardiovascular Disease
Diabetes
Drug Abuse
Infectious Disease
Herpes
HTLV
Respiratory Syncytial Virus
Hepatitis
Lyme Disease
Babesiosis
Gonorrhea, Syphilis and Chlamydia
Trichomonas Vaginalis
HIV/AIDS
Helicobacter Pylori
Influenza
Coronavirus
Mononucleosis
Streptococcus
Osteoporosis
Pregnancy and Fertility
Chapter 3: POC Blood Glucose Tests
Introduction and Scope
Types of Blood Glucose Testing
Fasting Blood Sugar (FBS)
2-Hour Postprandial Blood Sugar (PPBS)
Random Blood Sugar
Glucose Tolerance Test
Glucose Urine Test
Glycated Hemoglobin (HbA1c)
Products
Blood Glucose Self-Testing
- Table 3-1: Selected Glucose Self-Test Meter Innovations
- Table 3-2: Selected Apps and Glucose Management IT
Continuous Self-Testing
Glycated Hemoglobin Tests
- Table 3-3: Selected POC HbA1c Testing Systems and Related Products
Professional
Market Size and Growth
- Table 3-4: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
- Figure 3-1: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
- Table 3-5: Global POC Diabetes Sales, by Test Category, 2025-2030 ($ million) [Glucose, Continuous; Glucose, Professional; Glucose, Self-test; HbA1c, POC]
Regional Analysis
- Figure 3-2: POC Blood Glucose Testing Regional Market Analysis, 2025 (%)
POC Glucose Self-Testing
- Table 3-6: Global POC Glucose Self-Testing Market (excludes continuous glucose devices), 2025-2030 (US$ millions, manufacturer level)
POC Continuous Glucose Self-Testing
- Table 3-7: Global POC Continuous Glucose Self-Testing Market, 2025-2030 (US$ millions, manufacturer level)
POC Glucose Professional Testing
- Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing), 2025-2030 (US$ millions, manufacturer level)
POC HbA1c Testing
- Table 3-9: Global POC Glucose HbA1c Professional Testing Market 2025-2030 (US$ millions, manufacturer level)
Competitive Analysis
- Table 3-10: Global POC Blood Glucose Testing Market (BGM, CGM, HbA1c), Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
- Figure 3-3: Global POC Glucose Test Manufacturers, Market Share of Leading Suppliers, 2025 (%)
Chapter 4: POC Blood and Electrolytes Testing Market
Introduction and Scope
Types of Blood and Electrolytes Tests
Hemoglobin/Hematocrit
WBC and Other
Blood Gases
Electrolytes
Products
- Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2025
- Table 4-2: Selected POC Hematology Analyzer Systems, 2025
Market Size and Growth
- Table 4-3: Global POC Blood and Electrolytes Testing Market* Analysis, 2025-2030 (US$ millions, manufacturer level)
- Figure 4-1: Global POC Blood and Electrolytes Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
- Table 4-4: Global POC Blood & Electrolytes Revenues, by Test Category, 2025-2030 (US$ millions)
Regional Analysis
- Figure 4-2: POC Blood and Electrolytes Testing Regional Market Analysis, 2025 (%)
POC Blood and Electrolyte Self-Testing
- Table 4-5: Global POC Blood and Electrolyte Self-Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
POC Blood and Electrolyte Professional Testing
- Table 4-6: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Competitive Analysis
- Table 4-7: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
- Figure 4-3: Global POC Blood and Electrolyte Testing Market Manufacturers, Market Share of Leading Suppliers, 2025 (%)
Chapter 5: POC Rapid Coagulation
Introduction and Scope
Products
- Table 5-1: Selected POC Coagulation Test Innovations
Platelet Testing
- Table 5-2: Selected Platelet Activity Test Innovations
Market Size and Growth
- Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
- Figure 5-1: Global Rapid Coagulation Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Regional Analysis
- Figure 5-2: POC Rapid Coagulation Testing Regional Market Analysis, 2025 (%)
POC Rapid Coagulation Self-Testing
- Table 5-4: POC Rapid Coagulation Self-Testing, Market Analysis, 2025-2030 (US$ millions, manufacturer level)
POC Rapid Coagulation Professional Testing
- Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Competitive Analysis
- Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
- Figure 5-3: Global POC Rapid Coagulation Testing Market, Market Share of Leading Suppliers, 2025 (%)
Chapter 6: POC Rapid Cardiac Markers
Introduction and Scope
Products
Market Size and Growth
- Table 6-1: Total Rapid Total Rapid Cardiac Marker Test Market Analysis, 2025-2030 (US$ millions, manufacturer level)
- Figure 6-1: Total POC Rapid Cardiac Marker Test Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Regional Analysis
- Figure 6-2: POC Rapid Cardiac Markers Testing Regional Market Analysis, 2025 (%)
Competitive Analysis
- Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
- Figure 6-3: Global POC Cardiac Markers Test Manufacturers, 2025 (%)
Chapter 7: POC Substance Abuse
Introduction and Scope
Products
Urine
Oral
Blood-based
Hair
Nicotine and Alcohol
Market Size and Growth
- Table 7-1: Global POC Drugs-of-Abuse Testing* Market Analysis, 2025-2030 (US$ millions, manufacturer level)
- Figure 7-1: Global POC Drugs-of-Abuse Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Regional Analysis
- Figure 7-2: POC Substance Abuse Testing Regional Market Analysis, 2025 (%)
POC Drugs of Abuse Self-Testing
- Table 7-2: Global POC Drugs of Abuse Self-Testing Market, 2025-2030 (US$ millions, manufacturer level)
POC Drugs of Abuse Professional Testing
- Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Competitive Analysis
- Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
- Figure 7-3: Global POC Drug of Abuse Testing Manufacturers, 2025 (%)
Chapter 8: POC Pregnancy and Fertility Testing
Introduction and Scope
Products
- Table 8-1: Selected Pregnancy and Fertility CLIA-Waived Instruments, Devices, and Assays
Market Size and Growth
- Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
- Figure 8-1: Global POC Pregnancy and Fertility Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Regional Analysis
- Figure 8-2: POC Pregnancy and Fertility Testing Regional Market Analysis, 2025 (%)
POC Pregnancy and Fertility Self-Testing
- Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
POC Pregnancy and Fertility Professional Testing
- Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Competitive Analysis
- Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
- Figure 8-3: Global POC Pregnancy and Fertility Testing Manufacturers, 2025 (%)
Chapter 9: POC Colon Cancer Screening/Fecal Occult Blood Testing
Introduction and Scope
Products
- Table 9-1: Selected POC and Home-Based Colon Cancer Screening Tests
Market Size and Growth
- Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
- Figure 9-1: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Regional Analysis
- Figure 9-2: POC Colon Cancer Screening/FOB Testing Regional Market Analysis, 2025 (%)
POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
- Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
POC Colon Cancer Screening/Fecal Occult Blood Professional Testing
- Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Competitive Analysis
- Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
- Figure 9-3: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers, 2025 (%)
Chapter 10: POC Infectious Disease Testing
Introduction and Scope
Products
HIV and Hepatitis
Respiratory
STD/STI
Tropical Diseases
Lyme Disease
TB
Zika
Anthrax
Other Bacteria and Viruses
Hospital Acquired Infections and Sepsis
Sepsis
C. difficile
- Table 10-1: Selected Innovations in POC Infectious Disease Diagnostics
Market Size and Growth
- Table 10-2: Global POC Infectious Disease (including COVID-19) Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
- Figure 10-1: Global POC Infectious Disease (including COVID-19) Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Regional Analysis
- Figure 10-2: POC Infectious Disease (including COVID-19) Testing Regional Market Analysis, 2025 (%)
POC Infectious Disease Self-Testing
- Table 10-3: POC Infectious Disease Self-Testing (including COVID-19) Market Analysis, 2025-2030 (US$ millions, manufacturer level)
POC Infectious Disease Professional Testing
- Table 10-4: POC Infectious Disease Professional Testing (including COVID-19) Market Analysis, 2025-2030 (US$ millions, manufacturer level)
POC Infectious Disease Testing by Disease Type
- Table 10-5: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market, by Disease Type, 2025 (US$ millions) [C. difficile, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Malaria, Respiratory, STD, Others]
Competitive Analysis
- Table 10-6: Global POC Infectious Disease, including COVID-19 Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
- Figure 10-3: Global POC Infectious Disease Test Manufacturers, 2025 (%)
Chapter 11: POC Lipid Testing
Introduction and Scope
Products
Market Size and Growth
- Table 11-1: Global POC Lipid Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
- Figure 11-1: Global POC Lipid Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Regional Analysis
- Figure 11-2: POC Lipid Testing Regional Market Analysis, 2025 (%)
POC Lipid Self-Testing
- Table 11-2: POC Lipid Self-Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
POC Lipid Professional Testing
- Table 11-3: POC Lipid Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Competitive Analysis
- Table 11-4: Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
- Figure 11-3: Global POC Lipid Testing Manufacturers, 2025 (%)
Chapter 12: POC Cancer Tumor Marker Testing
Introduction and Scope
Products
- Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications
Market Size and Growth
- Table 12-2: Global POC Cancer Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
- Figure 12-1: Global POC Cancer Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Regional Analysis
- Figure 12-2: POC Cancer Tumor Marker Testing Regional Market Analysis, 2025 (%)
Competitive Analysis
- Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
- Figure 12-3: Global POC Cancer Testing Manufacturers, 2025 (%)
Chapter 13: POC Urine Testing
Introduction and Scope
Products
Market Size and Growth
- Table 13-1: Global POC Urine Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
- Figure 13-1: Global POC Urine Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Regional Analysis
- Figure 13-2: POC Urine Testing Regional Market Analysis, 2025 (%)
POC Urine Self-Testing
- Table 13-2: POC Urine Self-Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
POC Urine Test Professional Testing
- Table 13-3: POC Urine Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Competitive Analysis
- Table 13-4: Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
- Figure 13-3: Global POC Urine Strip Testing Manufacturers, 2025 (%)
Chapter 14: Miscellaneous POC Testing
Introduction and Scope
Microbiology
- Table 14-1: Global POC Microbiology Test Sales, 2025-2030 (US$ millions)
TSH
- Table 14-2: Global POC Thyroid-Stimulating Hormone (TSH) Test Sales, 2025-2030 (US$ millions)
Allergy
- Table 14-3: Global POC Allergy Test Sales, 2025-2030 (US$ millions)
Autoimmune
- Table 14-4: Global POC Autoimmune Test Sales, 2025-2030 (US$ millions)
Others
- Table 14-5: Global POC Other Test Sales, 2025-2030 (US$ millions)
Miscellaneous POC Testing Market Size and Growth
- Table 14-6: Global Miscellaneous POC Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
- Figure 14-1: Global Miscellaneous POC Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
- Table 14-7: Global POC Miscellaneous Sales, by Test Category, 2025-2030 (US$ millions) [Allergy, Autoimmune, Microbiology, TSH, Others]
POC Miscellaneous Test Sales by Setting
- Table 14-8: POC Miscellaneous Test Sales by Setting 2025-2030 ($millions)
Regional Analysis
- Figure 14-2: POC Miscellaneous Testing Regional Market Analysis, 2025 (%)
Chapter 15: Issues and Trends
Introduction and Scope
Tariffs and the POC Industry
Breath Test Advances
- Table 15-1: Selected Disease Markers in Exhaled Breath
Mobile Healthcare Technologies
Telehealth
Early Sepsis Detection
Personalized Medicine
Regulatory Hurdles
Reimbursement Challenges
PAMA
POC and Molecular Diagnostics
- Table 15-2: Selected Market Available Molecular POC Diagnostic Platforms
China as a POC Market
Advancing POC Technologies
POC Connectivity
Multiplexed POC Testing
Emerging Non-invasive Technologies
Saliva and Swab
Optical Techniques
Volatolomics
POC and Antimicrobial Stewardship
Artificial Intelligence in POC
Hybrid Emergency Department /Urgent Care Centers and POC
Digital Diagnostics
Microfluidics and POC
Chapter 16: Total Global POC Testing Market and Competitor Analysis
Market Overview
- Table 16-1: Global POC Test Market, 2025-2030 (US$ millions, manufacturer level)
- Figure 16-1: Global POC Test Market, 2025-2030 (US$ millions, manufacturer level)
Market Analysis by Product Categories
- Table 16-2: Global POC Testing Market Analysis, by Product Category, 2025 (US$ millions) [Professional Testing, Self-Testing]
Market Analysis by Subcategory
POC Self-Testing
- Table 16-3: Global POC Self-Testing Market Analysis, by Product Category, 2025 (US$ millions) [Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose (includes CGM), Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Miscellaneous]
- Figure 16-2: Global POC Self-Testing Market Analysis, by Product Category, 2025 (%) [Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose (includes CGM), Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Miscellaneous]
POC Professional Testing
- Table 16-4: Global POC Professional Testing Market Analysis, by Product Subcategory, 2025 (US$ millions) [Blood & Electrolytes, Cardiac Markers, Cancer Tumor Markers, Drugs of Abuse, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Rapid Coagulation, Urine, Miscellaneous]
- Figure 16-3: Global POC Professional Testing Market Analysis, by Product Subcategory, 2025 (%) [Blood & Electrolytes, Cardiac Markers, Cancer Tumor Markers, Drugs of Abuse, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Rapid Coagulation, Urine, Miscellaneous]
Market Analysis by Country
United States
- Table 16-5: US POC Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Europe
- Table 16-6: Europe POC Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Germany
France
United Kingdom (UK)
Switzerland
Other (Russia)
- Figure 16-4: European POC Testing Market Share, by Country, 2025 (%)
Japan
- Table 16-7: Japan POC Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
Rest of World
Latin America
China
India
South Korea
Vietnam and Other Southeast Asia
- Table 16-8: Global POC Testing Market Analysis, by Rest of World Region/Country, 2025 (US$ millions) [Australia; China; India; Latin America, Middle East and Canada; South Korea and other Asian countries; Other]
- Figure 16-5: Rest of World POC Testing Market Share, by Country, 2025 (%) [Australia, China, India, Latin America, South Korea, Other]
- Table 16-9: Global POC Testing Analysis, by Region/Country, 2025 (US$ millions)
- Figure 16-6: Global POC Testing Market Analysis, Market Share by Region/Country, 2025 (%)
Competitive Analysis
- Table 16-10: Global Top POC Testing Market Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
- Figure 16-7: Global POC Testing Market Share, by Leading Suppliers, 2025 (%)
Related products
Clinical Laboratory Services Market, 8th Edition
May 18, 2023
Laboratories are the workhorse of diagnostic services for the IVD market. These laboratories play a vital role in providing analysis of a wide range of disorders and diseases including pathology, immunology, cholesterol testing, allergy testing, urinalysis, genetic testing and many more. Kalorama Information’s Clinical Laboratory Services Market, 8th Edition is your comprehensive resource for insights…
Price range: $4,000.00 through $6,000.00
At-Home Diagnostic Testing Markets and Trends, 2023
June 6, 2023
Kalorama Information’s report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV, and Other Tests), 2023, delves into the expanding world of at-home and home collection tests. The at-home in vitro diagnostic (IVD) testing market comprises tests that can be purchased over the counter or online, where patients collect specimens and receive results within…
Price range: $4,000.00 through $6,000.00
Histology and Cytology IVD Market Update, 2024
May 21, 2024
Histology and cytology have long been essential components of pathological laboratories, offering critical insights into cells, tissues, and organs. Through histopathological examinations, a variety of diseases, including cancer, can be accurately diagnosed. Physicians rely heavily on pathological information to determine treatment plans and prognoses.
Histology and Cytology IVD Market Update, 2024 provides an in-depth competitive analysis…
Price range: $5,000.00 through $7,875.00
